We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-13.86%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.39B
AUM Growth
+$23.5M
Cap. Flow
+$245M
Cap. Flow %
17.64%
Top 10 Hldgs %
24.95%
Holding
4,841
New
999
Increased
1,367
Reduced
1,469
Closed
908

Sector Composition

Rank Sector Weight
1 Healthcare 6.26%
2 Financials 5.86%
3 Technology 5.03%
4 Energy 4.85%
5 Consumer Discretionary 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSVB
3251
DELISTED
Mid-Southern Bancorp, Inc.
MSVB
$3K ﹤0.01%
251
+151
+151% +$1.84K
BBIG
3252
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
$3K ﹤0.01%
+44
New +$3.63K
TA
3253
DELISTED
TravelCenters of America LLC
TA
$3K ﹤0.01%
+167
New +$3.71K
PTNR
3254
DELISTED
Partner Communications
PTNR
$3K ﹤0.01%
564
+364
+182% +$1.83K
HZN
3255
DELISTED
Horizon Global Corporation
HZN
$3K ﹤0.01%
2,007
-8,687
-81% -$33.9K
QUMU
3256
DELISTED
Qumu Corp.
QUMU
$3K ﹤0.01%
+1,471
New +$3.45K
STOR
3257
DELISTED
STORE Capital Corporation
STOR
$3K ﹤0.01%
90
-510
-85% -$14.9K
AVCT
3258
DELISTED
American Virtual Cloud Technologies, Inc. Common Stock
AVCT
$3K ﹤0.01%
21
-13
-38% -$1.96K
IBMK
3259
DELISTED
iShares iBonds Dec 2022 Term Muni Bond ETF
IBMK
$3K ﹤0.01%
+100
New +$2.54K
SRLP
3260
DELISTED
SPRAGUE RESOURCES LP
SRLP
$3K ﹤0.01%
+178
New +$3.74K
CCXI
3261
DELISTED
ChemoCentryx, Inc.
CCXI
$3K ﹤0.01%
257
-369
-59% -$3.89K
MN
3262
DELISTED
MANNING & NAPIER, INC.
MN
$3K ﹤0.01%
1,433
+1,263
+743% +$2.62K
AVLR
3263
DELISTED
Avalara, Inc.
AVLR
$3K ﹤0.01%
+100
New +$3.23K
TVTY
3264
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$3K ﹤0.01%
+107
New +$3.56K
HSTO
3265
DELISTED
Histogen Inc. Common Stock
HSTO
$3K ﹤0.01%
7
+4
+133% +$3.11K
FLXN
3266
DELISTED
Flexion Therapeutics, Inc.
FLXN
$3K ﹤0.01%
300
-48
-14% -$753
CBMB
3267
DELISTED
CBM Bancorp, Inc.
CBMB
$3K ﹤0.01%
+200
New +$2.5K
TRMT
3268
DELISTED
Tremont Mortgage Trust Common Shares of Beneficial Interest
TRMT
$3K ﹤0.01%
+300
New +$3.18K
KIN
3269
DELISTED
Kindred Biosciences, Inc.
KIN
$3K ﹤0.01%
236
+174
+281% +$2.19K
FBSS
3270
DELISTED
Fauquier Bankshares Inc
FBSS
$3K ﹤0.01%
+177
New +$3.87K
QEP
3271
DELISTED
QEP RESOURCES, INC.
QEP
$3K ﹤0.01%
534
-10,016
-95% -$88K
CCR
3272
DELISTED
CONSOL Coal Resources LP
CCR
$3K ﹤0.01%
+200
New +$3.61K
FHK
3273
DELISTED
First Trust Hong Kong AlphaDEX Fund
FHK
$3K ﹤0.01%
+100
New +$3.41K
AKCA
3274
DELISTED
Akcea Therapeutics Inc
AKCA
$3K ﹤0.01%
+98
New +$2.75K
ZN
3275
DELISTED
Zion Oil & Gas, Inc.
ZN
$3K ﹤0.01%
7,005
-179
-2% -$155

Similar funds

Tower Research Capital (TRC)'s Q4 2018 Portfolio in Review

As of Q4 2018, Tower Research Capital (TRC) held 4,841 positions worth $1.39B, up 1.7% from $1.36B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Tower Research Capital (TRC) deployed $245M of net new capital in Q4 2018, opening 999 new positions and adding to 1,367 existing holdings. Its largest new stake was iShares S&P 500 Value ETF: 55,235 shares worth $5.59M.

By sector, the portfolio is most concentrated in Healthcare at 6.3% of assets, down from 6.8% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $124M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2018 buy was iShares S&P 500 Value ETF: 55,235 shares worth $5.59M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2018, an estimated $123M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $124M.
  • Tower Research Capital (TRC) fully exited State Street Energy Select Sector SPDR ETF in Q4 2018, selling an estimated $26.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 25% of its $1.39B portfolio in Q4 2018.
  • Tower Research Capital (TRC) opened 999 new positions and closed 908 in Q4 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 1.7% quarter-over-quarter to $1.39B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2018, filed 14 Feb 2019.